First Tracks Biotherapeutics
Biotechnology; Research📍 San Diego, California
First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033, a CD122 antagonist in development for celiac disease and eosinophilic esophagitis; rosnilimab, a pathogenic T cell depleter in development for rheumatoid arthritis; and ANB101, a BDCA2 modulator.
Open Positions at First Tracks Biotherapeutics
0 positions available
No open positions at the moment
Check back later for new opportunities!